Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 24% ± 9% | |
pericyte | 6 studies | 19% ± 4% | |
GABAergic neuron | 5 studies | 33% ± 19% | |
glutamatergic neuron | 4 studies | 37% ± 21% | |
epithelial cell | 4 studies | 26% ± 3% | |
neuron | 4 studies | 29% ± 15% | |
oligodendrocyte | 4 studies | 23% ± 7% | |
non-classical monocyte | 3 studies | 27% ± 7% | |
retinal bipolar neuron | 3 studies | 25% ± 3% | |
microglial cell | 3 studies | 22% ± 2% | |
smooth muscle cell | 3 studies | 20% ± 5% | |
amacrine cell | 3 studies | 22% ± 4% | |
retina horizontal cell | 3 studies | 20% ± 3% | |
rod bipolar cell | 3 studies | 25% ± 7% | |
macrophage | 3 studies | 18% ± 1% | |
astrocyte | 3 studies | 20% ± 4% | |
interneuron | 3 studies | 34% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 6585.10 | 652 / 653 | 100% | 45.46 | 605 / 605 |
brain | 100% | 8089.34 | 2637 / 2642 | 100% | 52.39 | 705 / 705 |
prostate | 100% | 6093.80 | 245 / 245 | 100% | 35.46 | 501 / 502 |
skin | 100% | 9586.70 | 1809 / 1809 | 100% | 39.86 | 471 / 472 |
uterus | 100% | 8214.96 | 170 / 170 | 100% | 35.24 | 458 / 459 |
breast | 100% | 6024.24 | 458 / 459 | 100% | 33.57 | 1114 / 1118 |
kidney | 100% | 4335.43 | 89 / 89 | 99% | 27.52 | 894 / 901 |
ovary | 100% | 8425.42 | 180 / 180 | 99% | 23.66 | 426 / 430 |
esophagus | 100% | 7251.82 | 1445 / 1445 | 99% | 24.08 | 181 / 183 |
lung | 100% | 6491.71 | 576 / 578 | 98% | 25.85 | 1137 / 1155 |
bladder | 100% | 5691.48 | 21 / 21 | 98% | 24.04 | 494 / 504 |
intestine | 100% | 5601.50 | 963 / 966 | 98% | 21.73 | 517 / 527 |
stomach | 100% | 3810.93 | 359 / 359 | 98% | 22.82 | 279 / 286 |
adrenal gland | 98% | 4415.94 | 254 / 258 | 98% | 48.99 | 226 / 230 |
pancreas | 95% | 2455.05 | 311 / 328 | 100% | 32.62 | 178 / 178 |
liver | 78% | 1522.01 | 177 / 226 | 99% | 23.26 | 400 / 406 |
adipose | 100% | 5802.67 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 103.82 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.45 | 29 / 29 |
spleen | 100% | 5116.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.86 | 1 / 1 |
blood vessel | 100% | 9018.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7289.59 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 5754.01 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5949.39 | 913 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0090051 | Biological process | negative regulation of cell migration involved in sprouting angiogenesis |
GO_0006954 | Biological process | inflammatory response |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0010830 | Biological process | regulation of myotube differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0014823 | Biological process | response to activity |
GO_0043393 | Biological process | regulation of protein binding |
GO_0030182 | Biological process | neuron differentiation |
GO_0010832 | Biological process | negative regulation of myotube differentiation |
GO_0042220 | Biological process | response to cocaine |
GO_0042113 | Biological process | B cell activation |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | HDAC5 |
Protein name | histone deacetylase (EC 3.5.1.98) Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9) Histone deacetylase 5 |
Synonyms | KIAA0600 |
Description | FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation by repressing transcription of myocyte enhancer MEF2C. During muscle differentiation, it shuttles into the cytoplasm, allowing the expression of myocyte enhancer factors. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. Serves as a corepressor of RARA and causes its deacetylation . In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response . . |
Accessions | ENST00000588261.1 ENST00000587135.1 Q9UQL6 ENST00000591714.5 ENST00000682912.1 [Q9UQL6-1] K7EJL4 K7EJZ7 ENST00000225983.10 [Q9UQL6-3] ENST00000588703.5 K7EJL6 ENST00000586802.5 [Q9UQL6-1] K7ES01 ENST00000336057.9 [Q9UQL6-2] |